Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific nTPM	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific nTPM	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific nTPM	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific nTPM	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific nTPM	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific nTPM	RNA tissue cell type enrichment	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific nTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific nTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Blood expression cluster	Tissue expression cluster	Cell line expression cluster	Single cell expression cluster	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	RNAsingleCellTypeSpecific
AGPAT4	dJ473J16.2, LPAAT-delta	ENSG00000026652	1-acylglycerol-3-phosphate O-acyltransferase 4	Q9NRZ5	6	161129967-161274061	Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism	Acyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 51.3	Cell type enriched	Detected in many	4	Oligodendrocytes: 384.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in many			Heart muscle - Fibroblasts, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA053287, HPA060525	Approved		Approved	Nucleoli,Golgi apparatus,Vesicles						Cluster 36: GdT-cells - Adaptive immune response	Cluster 70: Brain - Nervous system development	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus	Nucleoli, Vesicles	HPA053287: AB_2682101, HPA060525: AB_2684306	unprognostic (5.69e-2)	prognostic unfavorable (1.45e-4)	unprognostic (1.73e-1)	unprognostic (3.43e-2)	unprognostic (4.14e-2)	unprognostic (6.67e-3)	unprognostic (1.94e-4)	unprognostic (1.05e-1)	unprognostic (3.42e-2)	unprognostic (2.77e-2)	unprognostic (1.76e-3)	unprognostic (1.67e-1)	prognostic unfavorable (4.08e-4)	unprognostic (1.82e-2)	unprognostic (8.87e-2)	unprognostic (3.63e-4)	unprognostic (5.51e-2)	Oligodendrocytes
VRK2		ENSG00000028116	VRK serine/threonine kinase 2	Q86Y07	2	57907629-58159920	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Host-virus interaction	Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	9	Oligodendrocytes: 510.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB046459, HPA047503	Approved		Supported	Endoplasmic reticulum						Cluster 19: B-cells - Humoral immune response	Cluster 70: Brain - Nervous system development	Cluster 45: Non-specific - Cell proliferation	Cluster 8: Oligodendrocytes - Myelin sheath organization	Endoplasmic reticulum		CAB046459: AB_1858773, HPA047503: AB_2680071	unprognostic (1.87e-1)	unprognostic (5.84e-2)	unprognostic (4.65e-2)	unprognostic (1.33e-3)	unprognostic (1.27e-1)	unprognostic (1.60e-2)	prognostic unfavorable (6.32e-6)	unprognostic (3.90e-2)	unprognostic (4.76e-2)	unprognostic (2.96e-2)	prognostic unfavorable (4.65e-4)	unprognostic (1.36e-1)	prognostic unfavorable (4.66e-5)	unprognostic (3.48e-1)	unprognostic (1.62e-1)	unprognostic (2.99e-1)	unprognostic (3.56e-1)	Oligodendrocytes
FUT8		ENSG00000033170	Fucosyltransferase 8	Q9BYC5	14	65410592-65744121	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase	Congenital disorder of glycosylation, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 64.3	Cell type enriched	Detected in many	4	Oligodendrocytes: 962.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0	Low cancer specificity	Detected in all			Testis - Spermatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB017129, HPA043410	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol						Cluster 43: B-cells - Humoral immune response	Cluster 70: Brain - Nervous system development	Cluster 46: Non-specific - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus	Nucleoplasm, Cytosol	CAB017129: , HPA043410: AB_2678467	unprognostic (1.67e-1)	unprognostic (1.63e-1)	unprognostic (3.28e-2)	unprognostic (1.65e-3)	unprognostic (2.10e-1)	unprognostic (5.61e-2)	unprognostic (1.41e-1)	unprognostic (8.81e-2)	unprognostic (2.00e-2)	unprognostic (1.33e-3)	unprognostic (8.09e-2)	unprognostic (1.94e-1)	unprognostic (1.04e-3)	unprognostic (1.40e-1)	unprognostic (2.94e-1)	unprognostic (1.40e-1)	unprognostic (8.28e-3)	Oligodendrocytes
PLEKHH1	KIAA1200	ENSG00000054690	Pleckstrin homology, MyTH4 and FERM domain containing H1	Q9ULM0	14	67533290-67589612	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 158.0	Cell type enriched	Detected in many	8	Oligodendrocytes: 573.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		prostate cancer: 14.7	Prostate - Prostate glandular cells, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047707, HPA051964	Uncertain		Approved	Centrosome							Cluster 70: Brain - Nervous system development	Cluster 24: Prostate cancer - Lipid metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Centrosome		HPA047707: AB_2680126, HPA051964: AB_2681675	unprognostic (2.47e-2)	unprognostic (9.57e-2)	unprognostic (3.94e-2)	prognostic favorable (8.03e-5)	unprognostic (4.74e-1)	unprognostic (9.15e-3)	unprognostic (8.43e-5)	unprognostic (1.54e-2)	unprognostic (2.28e-1)	unprognostic (4.14e-2)	unprognostic (3.72e-2)	unprognostic (1.85e-1)	prognostic favorable (4.03e-7)	unprognostic (1.49e-1)	unprognostic (1.15e-2)	unprognostic (1.13e-1)	prognostic favorable (2.26e-4)	Oligodendrocytes
SLC44A1	CD92, CDW92, CHTL1, CTL1	ENSG00000070214	Solute carrier family 44 member 1	Q8WWI5	9	105244622-105439171	CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters	Transport		Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 284.9	Cell type enriched	Detected in all	9	Oligodendrocytes: 2307.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Liver - Hepatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064714, HPA074007	Enhanced		Supported	Nucleoplasm,Mitochondria					99000	Cluster 24: B-cells - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 59: Fibroblasts - Metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Mitochondria	Nucleoplasm	HPA064714: AB_2685334, HPA074007: 	unprognostic (3.49e-1)	unprognostic (2.25e-1)	unprognostic (1.27e-1)	unprognostic (6.54e-3)	unprognostic (4.77e-2)	unprognostic (1.74e-2)	unprognostic (2.21e-2)	prognostic unfavorable (4.49e-4)	unprognostic (2.48e-1)	unprognostic (1.95e-1)	unprognostic (1.64e-3)	unprognostic (6.20e-2)	prognostic favorable (1.85e-4)	unprognostic (2.13e-1)	unprognostic (2.07e-1)	unprognostic (1.33e-1)	unprognostic (2.07e-2)	Oligodendrocytes
TESK2		ENSG00000070759	Testis associated actin remodelling kinase 2	Q96S53	1	45343883-45491163	Enzymes, Plasma proteins, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Oligodendrocytes: 210.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in many			Prostate - Prostate glandular cells, Skin - Keratinocyte (other), Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027257, HPA063869	Uncertain		Enhanced	Nucleoplasm						Cluster 14: Monocytes - Unknown function	Cluster 69: Cerebellum - Gene expression regulation	Cluster 16: Skin cancer - Melanocyte processes	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm		HPA027257: AB_10602477, HPA063869: AB_2685137	unprognostic (2.95e-1)	prognostic favorable (2.22e-4)	unprognostic (3.90e-2)	unprognostic (5.04e-3)	unprognostic (6.03e-2)	unprognostic (1.87e-3)	unprognostic (3.22e-2)	unprognostic (1.43e-2)	unprognostic (5.15e-2)	unprognostic (2.96e-1)	unprognostic (2.28e-1)	unprognostic (2.86e-1)	unprognostic (4.36e-2)	unprognostic (2.49e-2)	unprognostic (1.13e-1)	unprognostic (4.37e-2)	unprognostic (2.01e-1)	Oligodendrocytes
PDE8A	HsT19550	ENSG00000073417	Phosphodiesterase 8A	O60658	15	84980440-85139145	Enzymes, Metabolic proteins, Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Oligodendrocytes: 914.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Skeletal muscle - Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007722	Approved		Approved	Golgi apparatus						Cluster 39: Non-specific - mRNA processing	Cluster 45: Intestine - Brush border	Cluster 40: Non-specific - Enzymes	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus		HPA007722: AB_1855130	unprognostic (1.68e-1)	unprognostic (2.83e-2)	unprognostic (4.81e-2)	unprognostic (4.97e-2)	unprognostic (6.25e-2)	unprognostic (3.47e-2)	unprognostic (2.97e-2)	unprognostic (3.94e-2)	unprognostic (1.03e-1)	unprognostic (2.45e-1)	unprognostic (8.99e-3)	unprognostic (2.75e-2)	unprognostic (3.42e-1)	unprognostic (3.72e-1)	unprognostic (4.26e-1)	unprognostic (1.31e-1)	unprognostic (1.94e-2)	Oligodendrocytes
FRYL	AF4p12, DKFZp686E205, KIAA0826, MOR2	ENSG00000075539	FRY like transcription coactivator	O94915	4	48497357-48780322	Disease related genes, Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 81.5	Cell type enriched	Detected in all	5	Oligodendrocytes: 1084.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enriched	Detected in many	5	basophil: 13.5	Lineage enriched	Detected in all	5	granulocytes: 13.5	Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031106, HPA031107	Supported		Approved	Microtubules,Cytokinetic bridge,Cytosol		Yes	No			Cluster 38: Basophils - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytosol	Microtubules, Cytokinetic bridge	HPA031106: AB_10600660, HPA031107: AB_10600536	unprognostic (7.50e-2)	unprognostic (9.72e-3)	unprognostic (6.68e-3)	unprognostic (3.22e-2)	unprognostic (5.37e-2)	unprognostic (2.03e-2)	unprognostic (3.59e-2)	unprognostic (4.80e-2)	unprognostic (4.67e-2)	unprognostic (2.08e-1)	unprognostic (2.41e-2)	unprognostic (4.68e-2)	unprognostic (2.62e-2)	unprognostic (3.32e-2)	unprognostic (1.66e-1)	unprognostic (1.01e-1)	unprognostic (1.29e-2)	Oligodendrocytes
PLD1		ENSG00000075651	Phospholipase D1	Q13393	3	171600404-171810950	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins	Lipid degradation, Lipid metabolism	Hydrolase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 86.8	Cell type enriched	Detected in many	4	Oligodendrocytes: 490.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in many		basophil: 8.3	Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Kidney - Proximal tubular cells, Liver - Hepatocytes, Prostate - Fibroblasts, Skin - Keratinocyte (other)	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB004527, HPA042396, HPA066938	Enhanced		Approved	Vesicles						Cluster 10: Basophils - Unknown function	Cluster 45: Intestine - Brush border	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles		CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: 	unprognostic (3.23e-1)	unprognostic (3.27e-1)	unprognostic (5.82e-2)	unprognostic (5.13e-2)	unprognostic (4.58e-1)	unprognostic (4.76e-2)	unprognostic (9.03e-2)	unprognostic (1.46e-1)	unprognostic (6.23e-2)	unprognostic (8.02e-2)	unprognostic (2.06e-2)	unprognostic (2.95e-2)	unprognostic (1.23e-1)	unprognostic (1.29e-1)	unprognostic (1.16e-1)	unprognostic (1.19e-1)	prognostic unfavorable (4.76e-6)	Oligodendrocytes
SYNJ2	INPP5H	ENSG00000078269	Synaptojanin 2	O15056	6	157981863-158099176	Enzymes, Metabolic proteins, Predicted intracellular proteins	Lipid metabolism	Hydrolase, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	brain: 116.2	Cell type enriched	Detected in many	4	Oligodendrocytes: 474.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Testis - Late spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031575	Approved		Approved	Microtubules,Cytosol						Cluster 1: Neutrophils - Mixed function	Cluster 70: Brain - Nervous system development	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 8: Oligodendrocytes - Myelin sheath organization	Microtubules	Cytosol	HPA031575: AB_10604101	prognostic unfavorable (2.63e-4)	unprognostic (1.94e-2)	unprognostic (7.61e-2)	unprognostic (1.25e-2)	unprognostic (1.48e-2)	unprognostic (7.68e-2)	unprognostic (1.24e-1)	unprognostic (7.06e-2)	unprognostic (2.91e-1)	unprognostic (7.29e-3)	unprognostic (1.26e-1)	unprognostic (1.36e-1)	prognostic unfavorable (4.02e-6)	unprognostic (1.66e-2)	unprognostic (3.75e-2)	unprognostic (1.75e-1)	unprognostic (9.45e-2)	Oligodendrocytes
SLCO1A2	OATP, OATP-A, OATP1A2, SLC21A3	ENSG00000084453	Solute carrier organic anion transporter family member 1A2	P46721	12	21264600-21419594	Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 82.0;choroid plexus: 28.6	Cell type enriched	Detected in some	4	Oligodendrocytes: 460.3	Cancer enhanced	Detected in some		testis cancer: 2.5	Low region specificity	Detected in all			Low immune cell specificity	Detected in single			Low lineage specificity	Detected in single			Cancer enhanced	Detected in many		testis cancer: 16.1	Liver - Hepatocytes, Lung - Alveolar cells type 1	Not detected	Not detected			Low region specificity	Detected in all			HPA071152			Supported	Plasma membrane		No	No			Cluster 1: Neutrophils - Mixed function	Cluster 70: Brain - Nervous system development	Cluster 52: Spermatids - Smell perception	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane		HPA071152: AB_2686350	unprognostic (5.43e-3)	unprognostic (2.33e-1)	unprognostic (1.28e-1)	unprognostic (8.59e-2)	unprognostic (1.08e-1)	unprognostic (6.36e-2)	unprognostic (7.63e-2)	unprognostic (1.53e-1)	unprognostic (3.82e-2)	unprognostic (1.54e-2)	unprognostic (1.51e-1)	unprognostic (8.82e-2)	unprognostic (1.66e-4)	unprognostic (2.52e-2)	unprognostic (3.20e-1)		unprognostic (1.24e-1)	Oligodendrocytes
NKAIN1	FAM77C, FLJ12650	ENSG00000084628	Sodium/potassium transporting ATPase interacting 1	Q4KMZ8	1	31179745-31239887	Predicted membrane proteins, Transporters				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Group enriched	Detected in some	5	adrenal gland: 24.2;brain: 19.9;skeletal muscle: 19.4;tongue: 11.9	Cell type enriched	Detected in some	11	Oligodendrocytes: 41.5	Group enriched	Detected in many	5	breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Neuroblastoma: 26.7	Colon - Colon enteroendocrine cells, Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006873	Uncertain										Cluster 70: Brain - Nervous system development	Cluster 6: BEWO - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA006873: AB_1848410	unprognostic (1.58e-2)	unprognostic (7.99e-2)	unprognostic (8.54e-2)	unprognostic (6.11e-5)	unprognostic (6.59e-2)	unprognostic (1.24e-1)	unprognostic (4.30e-4)	unprognostic (1.04e-2)	unprognostic (2.36e-1)	unprognostic (2.78e-2)	unprognostic (2.01e-2)	unprognostic (8.07e-2)	unprognostic (6.31e-9)	unprognostic (1.00e-2)	unprognostic (8.83e-3)	unprognostic (1.62e-4)	unprognostic (5.50e-2)	Oligodendrocytes
CORO7-PAM16		ENSG00000103426	CORO7-PAM16 readthrough		16	4340251-4420494	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level			Not detected	Not detected			Cell type enriched	Detected in single	4	Oligodendrocytes: 2.7	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected												HPA041657, HPA053586, HPA062721	Uncertain		Approved	Nucleoplasm,Microtubules,Mitochondria								Cluster 44: Myeloma - Humoral immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Mitochondria	Microtubules	HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849	unprognostic (2.95e-2)	unprognostic (2.46e-1)	unprognostic (1.44e-1)	unprognostic (2.46e-1)	unprognostic (2.11e-1)	unprognostic (1.24e-2)	unprognostic (2.11e-4)	unprognostic (4.39e-2)	unprognostic (9.83e-3)	unprognostic (1.20e-1)	unprognostic (8.75e-3)	unprognostic (1.05e-1)	unprognostic (1.38e-1)	unprognostic (1.79e-2)	unprognostic (2.59e-2)	unprognostic (2.19e-1)	unprognostic (3.85e-1)	Oligodendrocytes
MAG	GMA, S-MAG, SIGLEC-4A, SIGLEC4A	ENSG00000105695	Myelin associated glycoprotein	P20916	19	35292125-35313807	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion		Disease variant, Hereditary spastic paraplegia, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	33	brain: 731.4	Cell type enriched	Detected in some	12	Oligodendrocytes: 252.8	Cancer enriched	Detected in some	7	glioma: 20.3	Low region specificity	Detected in all			Immune cell enriched	Detected in single	12	plasmacytoid DC: 2.9	Lineage enriched	Detected in single	12	dendritic cells: 2.9	Cancer enriched	Detected in some	7	skin cancer: 7.9	Kidney - Intercalated cells	Region enhanced	Detected in all		white matter: 2742.2	Low region specificity	Detected in all			CAB009345, HPA012499	Enhanced									Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization			CAB009345: AB_670104, HPA012499: AB_1854238	unprognostic (2.70e-3)	unprognostic (2.70e-2)		unprognostic (8.06e-3)	unprognostic (1.23e-1)	unprognostic (6.93e-2)	unprognostic (3.74e-1)	unprognostic (1.50e-1)	unprognostic (2.39e-1)	unprognostic (1.06e-1)	unprognostic (2.00e-1)	unprognostic (5.62e-2)	unprognostic (5.18e-4)	unprognostic (6.29e-2)	unprognostic (2.19e-1)	unprognostic (8.87e-2)	unprognostic (1.66e-1)	Oligodendrocytes
STEAP1B		ENSG00000105889	STEAP family member 1B	Q6NZ63	7	22419444-22727613	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.9;choroid plexus: 4.5	Cell type enriched	Detected in some	4	Oligodendrocytes: 122.6	Cancer enhanced	Detected in many		melanoma: 5.8	Low region specificity	Detected in all			Group enriched	Detected in some	67	memory B-cell: 8.4;naive B-cell: 4.9	Lineage enriched	Detected in single	84	B-cells: 8.4	Cancer enhanced	Detected in many		skin cancer: 30.4	Breast - Endothelial cells, Testis - Spermatocytes																			Cluster 37: B-cells - Transcription	Cluster 73: Brain - Neuropeptide signaling	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 8: Oligodendrocytes - Myelin sheath organization				unprognostic (7.35e-2)	unprognostic (2.42e-1)	unprognostic (1.72e-2)	unprognostic (1.34e-3)	unprognostic (3.96e-2)	unprognostic (2.18e-1)	unprognostic (2.31e-5)	unprognostic (2.29e-3)	unprognostic (4.96e-2)	unprognostic (7.37e-3)	unprognostic (7.38e-2)	unprognostic (1.27e-2)	unprognostic (2.85e-10)	unprognostic (1.06e-4)	unprognostic (3.46e-2)	unprognostic (1.35e-1)	unprognostic (2.21e-3)	Oligodendrocytes
PRUNE2	A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367	ENSG00000106772	Prune homolog 2 with BCH domain	Q8WUY3	9	76611376-76906114	Predicted intracellular proteins, Predicted membrane proteins	Apoptosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 120.6;intestine: 110.9	Cell type enriched	Detected in many	5	Oligodendrocytes: 867.3	Cancer enhanced	Detected in many		renal cancer: 15.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		prostate cancer: 40.0	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Prostate - Smooth muscle cells, Thyroid - Smooth muscle cells	Low region specificity	Detected in all							HPA022470, HPA031079	Uncertain		Approved	Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol						Cluster 8: Neutrophils - Inflammatory response	Cluster 57: Non-specific - Angiogenesis	Cluster 24: Prostate cancer - Lipid metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus, Cytosol	Nucleoplasm, Nucleoli	HPA022470: AB_1845832, HPA031079: AB_10603230	unprognostic (1.21e-1)	unprognostic (3.65e-2)	unprognostic (6.06e-2)	unprognostic (2.13e-2)	unprognostic (3.23e-1)	unprognostic (2.43e-3)	unprognostic (8.56e-2)	unprognostic (1.15e-2)	unprognostic (3.60e-1)	unprognostic (8.69e-2)	unprognostic (2.11e-2)	unprognostic (9.79e-2)	prognostic favorable (1.37e-6)	unprognostic (7.75e-2)	unprognostic (1.06e-1)	unprognostic (3.25e-3)	unprognostic (3.80e-4)	Oligodendrocytes
ABCA2	ABC2	ENSG00000107331	ATP binding cassette subfamily A member 2	Q9BZC7	9	137007234-137028922	Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Transport	Translocase	Disease variant, Epilepsy, Intellectual disability	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	brain: 543.0	Cell type enriched	Detected in many	7	Oligodendrocytes: 367.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many				Low region specificity	Detected in all							HPA042886	Approved		Supported	Vesicles						Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 65: Breast cancer - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles		HPA042886: AB_2678213	unprognostic (1.01e-2)	unprognostic (9.21e-3)	unprognostic (9.59e-2)	unprognostic (6.15e-2)	unprognostic (1.02e-1)	unprognostic (8.08e-2)	unprognostic (2.20e-2)	unprognostic (1.13e-2)	unprognostic (5.61e-3)	unprognostic (1.76e-1)	unprognostic (2.93e-2)	unprognostic (2.74e-2)	unprognostic (6.78e-3)	unprognostic (3.14e-3)	unprognostic (1.37e-1)	unprognostic (2.80e-1)	unprognostic (1.36e-1)	Oligodendrocytes
TRIM2	CMT2R, KIAA0517, RNF86	ENSG00000109654	Tripartite motif containing 2	Q9C040	4	153152163-153339319	Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins	Ubl conjugation pathway	Transferase	Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 116.2	Cell type enriched	Detected in many	4	Oligodendrocytes: 1069.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in single		memory CD4 T-cell: 1.0	Low lineage specificity	Detected in single			Cancer enhanced	Detected in all		skin cancer: 45.5	Thyroid - Thyroid glandular cells									HPA035853, HPA035854	Supported		Uncertain	Centrosome						Cluster 4: T-regs - Cell cycle regulation	Cluster 45: Intestine - Brush border	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization	Centrosome		HPA035853: AB_10669533, HPA035854: AB_10669659	unprognostic (8.94e-2)	unprognostic (7.89e-2)	unprognostic (6.21e-3)	unprognostic (7.51e-3)	unprognostic (2.07e-2)	unprognostic (2.32e-1)	unprognostic (1.16e-2)	unprognostic (2.30e-3)	unprognostic (5.30e-2)	unprognostic (6.77e-2)	unprognostic (1.93e-2)	unprognostic (1.42e-2)	prognostic favorable (6.58e-14)	unprognostic (5.89e-2)	unprognostic (1.17e-2)	unprognostic (4.19e-2)	unprognostic (4.13e-2)	Oligodendrocytes
MAN2A1	GOLIM7, MANA2	ENSG00000112893	Mannosidase alpha class 2A member 1	Q16706	5	109689927-109869625	Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 107.8	Cell type enriched	Detected in many	9	Oligodendrocytes: 1999.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Liver - Hepatocytes, Testis - Spermatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022377, HPA026896	Enhanced		Supported	Golgi apparatus					110000000	Cluster 14: Monocytes - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 44: Myeloma - Humoral immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus		CAB022377: , HPA026896: AB_1853512	unprognostic (1.62e-2)	unprognostic (4.06e-2)	unprognostic (1.25e-2)	unprognostic (6.96e-2)	unprognostic (2.52e-1)	unprognostic (1.08e-1)	unprognostic (5.80e-2)	unprognostic (4.20e-2)	unprognostic (3.91e-1)	unprognostic (2.90e-2)	unprognostic (4.73e-2)	unprognostic (1.23e-1)	unprognostic (6.77e-3)	unprognostic (2.03e-2)	unprognostic (1.20e-2)	unprognostic (1.11e-3)	unprognostic (5.31e-3)	Oligodendrocytes
PLCL1	PLC-L, PLCE, PLCL, PPP1R127, PRIP	ENSG00000115896	Phospholipase C like 1 (inactive)	Q15111	2	197804593-198572581	Metabolic proteins, Predicted intracellular proteins		Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 65.3;tongue: 40.8	Cell type enriched	Detected in many	9	Oligodendrocytes: 1947.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Immune cell enhanced	Detected in single		T-reg: 1.4	Lineage enriched	Detected in single	6	T-cells: 1.4	Low cancer specificity	Detected in some			Liver - Hepatic stellate cells, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031849	Enhanced									Cluster 35: T-regs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA031849: AB_10602192	unprognostic (7.77e-3)	unprognostic (2.57e-1)	unprognostic (2.09e-1)	unprognostic (5.18e-3)	unprognostic (4.40e-2)	unprognostic (7.14e-2)	unprognostic (2.05e-1)	unprognostic (4.42e-3)	unprognostic (1.07e-1)	unprognostic (1.32e-1)	unprognostic (3.02e-2)	unprognostic (7.42e-2)	prognostic favorable (3.91e-7)	unprognostic (1.07e-4)	unprognostic (6.74e-2)	unprognostic (1.68e-1)	unprognostic (3.20e-2)	Oligodendrocytes
DNAJC6	KIAA0473, PARK19	ENSG00000116675	DnaJ heat shock protein family (Hsp40) member C6	O75061	1	65248219-65415871	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Chaperone, Hydrolase, Protein phosphatase	Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 81.5;retina: 52.8	Cell type enriched	Detected in many	4	Oligodendrocytes: 979.9	Cancer enriched	Detected in many	4	glioma: 5.9	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		testis cancer: 37.4		Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031182, HPA054917	Enhanced		Approved	Nucleoplasm,Plasma membrane,Cytosol							Cluster 77: Retina - Visual perception	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytosol	Nucleoplasm, Plasma membrane	HPA031182: AB_10611957, HPA054917: AB_2682641	unprognostic (6.99e-2)	unprognostic (2.00e-3)	unprognostic (3.19e-1)	unprognostic (7.94e-7)	unprognostic (1.59e-1)	unprognostic (7.61e-3)	unprognostic (1.87e-4)	unprognostic (2.98e-1)	unprognostic (1.89e-1)	unprognostic (4.14e-1)	unprognostic (4.22e-3)	unprognostic (1.53e-1)	prognostic favorable (2.81e-4)	unprognostic (1.43e-2)	unprognostic (1.12e-1)	unprognostic (1.36e-1)	unprognostic (8.67e-3)	Oligodendrocytes
MOB3B	C9orf35, FLJ13204, MOB1D, MOBKL2B	ENSG00000120162	MOB kinase activator 3B	Q86TA1	9	27325209-27529814	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.4	Cell type enriched	Detected in many	4	Oligodendrocytes: 407.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		memory B-cell: 2.5;myeloid DC: 2.7;naive B-cell: 2.9	Low lineage specificity	Detected in many			Cancer enhanced	Detected in many		cervical cancer: 13.2	Prostate - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA057744			Uncertain	Intermediate filaments,Cytosol						Cluster 23: Antigen presenting cells - Antigen presentation	Cluster 45: Intestine - Brush border	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Intermediate filaments, Cytosol		HPA057744: 	unprognostic (6.96e-3)	unprognostic (9.60e-2)	unprognostic (5.10e-3)	unprognostic (1.41e-1)	unprognostic (1.38e-1)	unprognostic (1.02e-1)	unprognostic (1.87e-1)	unprognostic (7.05e-2)	unprognostic (2.42e-1)	unprognostic (7.57e-3)	unprognostic (1.28e-1)	unprognostic (9.45e-2)	prognostic favorable (2.33e-10)	unprognostic (1.55e-1)	unprognostic (1.16e-1)	prognostic unfavorable (1.02e-4)	unprognostic (7.99e-2)	Oligodendrocytes
PLP1	GPM6C, PLP, SPG2	ENSG00000123560	Proteolipid protein 1	P60201	X	103773718-103792619	Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins			Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 7004.9	Cell type enriched	Detected in many	4	Oligodendrocytes: 4552.3	Group enriched	Detected in many	22	glioma: 160.5;melanoma: 75.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	7	skin cancer: 218.3	Adipose visceral - Smooth muscle cells, Colon - Enteric glia cells, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004128	Enhanced									Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA004128: AB_1079635	unprognostic (5.72e-2)	unprognostic (1.77e-2)	unprognostic (2.27e-2)	unprognostic (4.09e-3)	unprognostic (1.32e-1)	unprognostic (3.95e-2)		unprognostic (2.57e-2)	unprognostic (1.02e-1)	unprognostic (5.92e-2)	unprognostic (2.28e-2)	unprognostic (1.21e-1)	unprognostic (1.62e-5)	unprognostic (4.91e-2)	unprognostic (1.86e-1)	unprognostic (3.46e-2)	unprognostic (1.16e-2)	Oligodendrocytes
ATG4C	APG4C, AUTL1, AUTL3, FLJ14867	ENSG00000125703	Autophagy related 4C cysteine peptidase	Q96DT6	1	62784132-62865516	Enzymes, Predicted intracellular proteins	Autophagy, Protein transport, Transport, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	brain: 60.8	Cell type enriched	Detected in many	7	Oligodendrocytes: 424.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007049	Approved		Approved	Nucleoplasm,Cytosol						Cluster 23: Antigen presenting cells - Antigen presentation	Cluster 70: Brain - Nervous system development	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Cytosol		HPA007049: AB_1845159	unprognostic (1.28e-1)	unprognostic (2.69e-1)	prognostic favorable (9.83e-4)	unprognostic (7.43e-2)	unprognostic (1.17e-1)	unprognostic (1.70e-1)	unprognostic (3.76e-2)	unprognostic (8.36e-2)	unprognostic (1.83e-2)	unprognostic (1.30e-1)	unprognostic (3.77e-1)	unprognostic (1.93e-1)	unprognostic (5.66e-2)	unprognostic (1.81e-1)	unprognostic (4.17e-2)	unprognostic (3.26e-2)	unprognostic (1.19e-1)	Oligodendrocytes
TRPV5	CaT2, ECAC1	ENSG00000127412	Transient receptor potential cation channel subfamily V member 5	Q9NQA5	7	142908101-142933746	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 1.1;kidney: 4.4	Cell type enriched	Detected in some	7	Oligodendrocytes: 14.3	Not detected	Not detected			Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Low region specificity	Detected in some			HPA063175	Uncertain										Cluster 7: Kidney - Transmembrane transport	Cluster 39: Non-specific - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA063175: AB_2684954	unprognostic (7.44e-2)	unprognostic (3.93e-2)		unprognostic (1.22e-2)	unprognostic (4.20e-2)	unprognostic (1.98e-1)		unprognostic (3.26e-1)	unprognostic (3.05e-1)	unprognostic (2.78e-2)	unprognostic (1.07e-1)	unprognostic (7.95e-2)	unprognostic (7.73e-4)	unprognostic (4.87e-2)	unprognostic (3.41e-1)	unprognostic (4.58e-1)	unprognostic (7.76e-3)	Oligodendrocytes
HSD17B3	SDR12C2	ENSG00000130948	Hydroxysteroid 17-beta dehydrogenase 3	P37058	9	96235306-96302176	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Oxidoreductase	Disease variant, Pseudohermaphroditism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 15.1;testis: 36.7	Cell type enriched	Detected in some	5	Oligodendrocytes: 88.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		head and neck cancer: 1.2	Kidney - Proximal tubular cells	Not detected	Not detected			Not detected	Not detected			HPA056833	Enhanced		Approved	Vesicles							Cluster 78: Testis - Spermatogenesis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles		HPA056833: AB_2683252	unprognostic (2.78e-1)	unprognostic (6.61e-3)	unprognostic (1.03e-1)	unprognostic (5.76e-2)	unprognostic (1.15e-1)	unprognostic (1.55e-1)	unprognostic (3.08e-2)	unprognostic (6.15e-2)	unprognostic (1.74e-1)	unprognostic (5.13e-2)	unprognostic (3.26e-4)	unprognostic (3.45e-1)	unprognostic (5.48e-8)	unprognostic (8.47e-3)	unprognostic (1.15e-1)	unprognostic (7.24e-2)	unprognostic (3.11e-2)	Oligodendrocytes
PRRG1	PRGP1	ENSG00000130962	Proline rich and Gla domain 1	O14668	X	37349309-37457292	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 39.4	Cell type enriched	Detected in many	6	Oligodendrocytes: 216.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Breast - Endothelial cells, Colon - Endothelial cells, Skin - Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA078129			Approved	Nucleoplasm,Vesicles,Plasma membrane						Cluster 34: Basophils - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 68: Kidney - Mixed function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles, Plasma membrane	Nucleoplasm	HPA078129: AB_2686878	unprognostic (8.82e-2)	prognostic unfavorable (4.65e-4)	unprognostic (8.34e-2)	unprognostic (2.08e-3)	unprognostic (1.92e-1)	unprognostic (5.11e-3)	unprognostic (2.24e-2)	unprognostic (7.23e-3)	unprognostic (1.01e-2)	unprognostic (1.74e-2)	prognostic unfavorable (1.22e-4)	unprognostic (8.21e-2)	prognostic favorable (2.05e-7)	unprognostic (1.43e-2)	unprognostic (1.81e-1)	unprognostic (1.08e-2)	unprognostic (1.48e-1)	Oligodendrocytes
HAPLN2	BRAL1	ENSG00000132702	Hyaluronan and proteoglycan link protein 2	Q9GZV7	1	156619331-156625725	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	brain: 270.8	Cell type enriched	Detected in some	13	Oligodendrocytes: 190.8	Cancer enriched	Detected in some	10	glioma: 7.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	4	Rhabdoid: 2.8		Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045765	Enhanced				Secreted in brain						Cluster 70: Brain - Nervous system development	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA045765: AB_10964781	unprognostic (3.19e-3)	unprognostic (1.06e-1)	unprognostic (1.02e-2)	unprognostic (3.41e-1)	unprognostic (1.88e-1)	unprognostic (2.44e-1)	unprognostic (1.92e-1)	unprognostic (2.04e-3)	unprognostic (1.31e-1)	unprognostic (8.25e-2)	unprognostic (5.54e-3)	unprognostic (2.72e-2)	unprognostic (2.70e-2)	unprognostic (1.08e-1)	unprognostic (2.25e-1)	unprognostic (1.05e-1)	unprognostic (4.17e-3)	Oligodendrocytes
PRR5L	FLJ14213, PROTOR-2	ENSG00000135362	Proline rich 5 like	Q6MZQ0	11	36296288-36465204	Predicted intracellular proteins		Signal transduction inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4	Cell type enriched	Detected in many	5	Oligodendrocytes: 285.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in all			Low cancer specificity	Detected in many			Heart muscle - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA070174			Approved	Cytokinetic bridge,Cytosol		Yes	No			Cluster 38: Basophils - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytokinetic bridge, Cytosol		HPA070174: AB_2686231	unprognostic (6.76e-2)	unprognostic (1.61e-1)	unprognostic (3.48e-2)	prognostic favorable (7.30e-5)	unprognostic (2.34e-2)	unprognostic (1.21e-1)	unprognostic (1.63e-1)	unprognostic (7.45e-2)	unprognostic (3.61e-1)	unprognostic (1.46e-2)	unprognostic (3.03e-3)	unprognostic (2.12e-1)	prognostic unfavorable (7.71e-8)	prognostic unfavorable (4.86e-4)	unprognostic (1.66e-1)	unprognostic (1.44e-1)	unprognostic (2.98e-2)	Oligodendrocytes
DOCK10	KIAA0694, ZIZ3	ENSG00000135905	Dedicator of cytokinesis 10	Q96BY6	2	224765090-225042468	Plasma proteins, Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 83.1;lymphoid tissue: 32.1	Cell type enriched	Detected in many	4	Oligodendrocytes: 1704.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in all			Low cancer specificity	Detected in many			Lung - T-cells, Thyroid - T-cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol						Cluster 27: Non-specific - Gene expression	Cluster 32: Brain & Lymphoid tissue - Unknown function	Cluster 50: L-1236 & L-428 - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Cytosol		HPA058106: AB_2683606	unprognostic (6.95e-2)	unprognostic (1.41e-2)	unprognostic (1.05e-2)	unprognostic (2.03e-2)	unprognostic (1.14e-1)	unprognostic (1.55e-3)	unprognostic (1.19e-1)	unprognostic (6.92e-2)	unprognostic (3.44e-2)	unprognostic (3.80e-1)	unprognostic (3.22e-3)	unprognostic (3.39e-1)	unprognostic (1.24e-2)	unprognostic (1.01e-1)	unprognostic (2.99e-2)	unprognostic (2.54e-1)	unprognostic (7.72e-2)	Oligodendrocytes
ERMN	ERMIN, JN, KIAA1189	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	17	brain: 498.6;choroid plexus: 136.2	Cell type enriched	Detected in some	30	Oligodendrocytes: 274.6	Cancer enriched	Detected in some	4	glioma: 9.9	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	Leukemia: 2.0;lymphoma: 4.0;Myeloma: 6.8		Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038295, HPA038296	Enhanced		Approved	Plasma membrane,Cytosol						Cluster 33: Neutrophils - Chromatin organization	Cluster 70: Brain - Nervous system development	Cluster 44: Myeloma - Humoral immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane	Cytosol	HPA038295: AB_10805353, HPA038296: AB_10796217	unprognostic (7.89e-2)	unprognostic (9.06e-3)	unprognostic (2.71e-2)	prognostic favorable (6.93e-6)	unprognostic (1.06e-1)	unprognostic (2.02e-2)	unprognostic (9.14e-2)	unprognostic (1.79e-1)	unprognostic (4.57e-2)	unprognostic (4.40e-2)	unprognostic (1.07e-1)	unprognostic (5.49e-2)	unprognostic (1.46e-3)	unprognostic (2.84e-2)	unprognostic (7.96e-2)	unprognostic (9.97e-3)	unprognostic (5.76e-2)	Oligodendrocytes
ZNF189		ENSG00000136870	Zinc finger protein 189	O75820	9	101398873-101410660	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		epididymis: 86.0	Cell type enriched	Detected in many	4	Oligodendrocytes: 118.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034814	Uncertain		Approved	Intermediate filaments						Cluster 52: Eosinophils - Transcription	Cluster 68: Epididymis - Unknown function	Cluster 55: Non-specific - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Intermediate filaments		HPA034814: AB_10601030	unprognostic (3.87e-2)	unprognostic (3.47e-1)	unprognostic (5.30e-2)	unprognostic (2.75e-1)	unprognostic (6.45e-2)	unprognostic (1.42e-1)	unprognostic (1.26e-2)	unprognostic (3.59e-3)	unprognostic (1.70e-2)	unprognostic (1.15e-1)	unprognostic (1.38e-1)	unprognostic (1.10e-1)	prognostic favorable (5.32e-4)	unprognostic (3.31e-1)	unprognostic (4.58e-1)	unprognostic (1.86e-2)	unprognostic (6.57e-2)	Oligodendrocytes
ENPP2	ATX, PD-IALPHA, PDNP2	ENSG00000136960	Ectonucleotide pyrophosphatase/phosphodiesterase 2	Q13822	8	119557086-119673453	Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Chemotaxis, Lipid degradation, Lipid metabolism	Hydrolase	Cancer-related genes, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 383.3;choroid plexus: 753.4	Cell type enriched	Detected in many	4	Oligodendrocytes: 983.3	Cancer enhanced	Detected in all		renal cancer: 46.7	Low region specificity	Detected in all			Immune cell enriched	Detected in many	6	basophil: 53.8	Lineage enriched	Detected in many	8	granulocytes: 53.8	Cancer enhanced	Detected in many		Neuroblastoma: 83.4	Breast - Endothelial cells, Skeletal muscle - Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023700, HPA053652	Approved		Approved	Nucleoplasm,Golgi apparatus,Actin filaments	Secreted to blood				1200000000	Cluster 46: Basophils - DNA binding	Cluster 88: Choroid plexus - Transmembrane transport	Cluster 59: Fibroblasts - Metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Golgi apparatus	Actin filaments	HPA023700: AB_1848170, HPA053652: AB_2682218	unprognostic (1.17e-2)	unprognostic (6.29e-2)	unprognostic (3.63e-2)	unprognostic (3.93e-2)	unprognostic (1.23e-1)	unprognostic (1.37e-1)	unprognostic (9.70e-3)	unprognostic (7.14e-2)	unprognostic (1.29e-1)	unprognostic (1.26e-1)	prognostic favorable (2.07e-5)	unprognostic (5.54e-2)	unprognostic (3.14e-1)	unprognostic (2.37e-1)	unprognostic (5.18e-2)	unprognostic (2.37e-2)	unprognostic (1.50e-1)	Oligodendrocytes
TJAP1	PILT, TJP4	ENSG00000137221	Tight junction associated protein 1	Q5JTD0	6	43477523-43506556	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Oligodendrocytes: 110.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030164, HPA030165, HPA030166	Supported		Enhanced	Golgi apparatus						Cluster 46: Basophils - DNA binding	Cluster 35: Non-specific - Unknown function	Cluster 15: Non-specific - Protein binding	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus		HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858	unprognostic (5.05e-3)	unprognostic (2.82e-2)	unprognostic (6.89e-3)	unprognostic (1.03e-3)	unprognostic (3.09e-2)	unprognostic (4.50e-3)	prognostic unfavorable (9.02e-6)	unprognostic (4.27e-2)	unprognostic (4.76e-2)	unprognostic (1.43e-1)	unprognostic (5.53e-3)	unprognostic (1.61e-3)	prognostic unfavorable (1.13e-4)	unprognostic (2.29e-1)	unprognostic (2.95e-1)	unprognostic (5.15e-3)	unprognostic (7.51e-3)	Oligodendrocytes
TTLL7	FLJ23033	ENSG00000137941	Tubulin tyrosine ligase like 7	Q6ZT98	1	83865024-83999150	Predicted intracellular proteins	Differentiation, Neurogenesis	Developmental protein, Ligase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 57.1	Cell type enriched	Detected in many	5	Oligodendrocytes: 1471.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052249	Approved									Cluster 10: Basophils - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 42: Sarcoma - Muscle contraction	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA052249: AB_2681773	unprognostic (9.68e-2)	unprognostic (3.78e-1)	unprognostic (3.15e-1)	unprognostic (2.82e-2)	unprognostic (6.56e-2)	unprognostic (1.30e-1)	unprognostic (1.25e-3)	unprognostic (1.95e-1)	unprognostic (3.06e-1)	unprognostic (3.63e-2)	unprognostic (7.93e-4)	unprognostic (4.34e-1)	unprognostic (1.84e-3)	unprognostic (3.32e-1)	unprognostic (2.67e-2)	unprognostic (3.77e-3)	unprognostic (1.04e-3)	Oligodendrocytes
SLAIN1	C13orf32, FLJ30046	ENSG00000139737	SLAIN motif family member 1	Q8ND83	13	77697687-77764242	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	7	brain: 412.9	Cell type enriched	Detected in many	5	Oligodendrocytes: 1021.3	Cancer enhanced	Detected in many		glioma: 25.1	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in single			Cancer enhanced	Detected in many		Bone cancer: 60.3;Myeloma: 59.3	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Mesothelial cells, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 35: T-regs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 14: Bone cancer - Transcription	Cluster 8: Oligodendrocytes - Myelin sheath organization				unprognostic (8.76e-5)	unprognostic (1.78e-2)	unprognostic (3.11e-1)	unprognostic (3.25e-3)	unprognostic (1.60e-1)	unprognostic (3.78e-2)	unprognostic (2.13e-1)	unprognostic (1.39e-2)	unprognostic (6.20e-2)	prognostic favorable (9.07e-4)	unprognostic (4.80e-3)	unprognostic (3.83e-3)	unprognostic (2.16e-2)	unprognostic (4.53e-2)	unprognostic (1.37e-1)	unprognostic (3.34e-1)	unprognostic (1.97e-2)	Oligodendrocytes
DOCK5	FLJ21034	ENSG00000147459	Dedicator of cytokinesis 5	Q9H7D0	8	25184689-25418082	Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 86.0	Cell type enriched	Detected in many	5	Oligodendrocytes: 745.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in many		neutrophil: 30.7	Lineage enriched	Detected in many	4	granulocytes: 30.7	Low cancer specificity	Detected in all			Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017719, HPA056837	Approved		Enhanced	Cytosol		No	No			Cluster 50: Neutrophils - Cellular senescence	Cluster 70: Brain - Nervous system development	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytosol		HPA017719: AB_1847820, HPA056837: AB_2683253	unprognostic (2.16e-1)	unprognostic (3.55e-3)	unprognostic (1.25e-2)	prognostic favorable (1.91e-4)	unprognostic (8.44e-2)	unprognostic (1.24e-1)	unprognostic (2.61e-2)	unprognostic (2.88e-2)	unprognostic (1.69e-2)	unprognostic (4.21e-2)	unprognostic (4.18e-3)	unprognostic (3.00e-1)	prognostic unfavorable (1.18e-6)	unprognostic (2.81e-1)	unprognostic (3.07e-1)	unprognostic (1.30e-2)	unprognostic (2.25e-1)	Oligodendrocytes
ST18	KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387	ENSG00000147488	ST18 C2H2C-type zinc finger transcription factor	O60284	8	52110839-52460959	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	brain: 82.1	Cell type enriched	Detected in some	43	Oligodendrocytes: 3828.2	Cancer enhanced	Detected in single		pancreatic cancer: 0.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		lung cancer: 6.8	Colon - Colon enteroendocrine cells, Kidney - Proximal tubular cells, Pancreas - Alpha cells, Pancreas - Beta cells, Stomach - Gastric enteroendocrine cells, Thyroid - Parafollicular cells	Region enhanced	Detected in all		cerebellum: 40.2	Low region specificity	Detected in all			HPA044919	Uncertain										Cluster 70: Brain - Nervous system development	Cluster 41: Non-specific - Cilium assembly	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA044919: AB_10959756	unprognostic (3.66e-1)	unprognostic (4.34e-2)	unprognostic (7.47e-2)	unprognostic (2.04e-2)	unprognostic (2.78e-1)	unprognostic (2.42e-2)	unprognostic (1.22e-1)	unprognostic (7.11e-2)	unprognostic (2.12e-1)	unprognostic (1.58e-1)	unprognostic (1.55e-3)	unprognostic (2.82e-1)	unprognostic (2.53e-5)	unprognostic (3.29e-1)	unprognostic (1.35e-1)	unprognostic (9.34e-2)	unprognostic (9.84e-3)	Oligodendrocytes
FAM13C	FAM13C1	ENSG00000148541	Family with sequence similarity 13 member C	Q8NE31	10	59246130-59363181	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 68.0	Cell type enriched	Detected in many	6	Oligodendrocytes: 450.4	Cancer enhanced	Detected in some		prostate cancer: 3.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Neuroblastoma: 6.9;Rhabdoid: 11.7	Liver - Hepatic stellate cells, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037888	Approved		Approved	Nucleoplasm,Cytosol							Cluster 70: Brain - Nervous system development	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Cytosol		HPA037888: AB_10962981	unprognostic (3.68e-1)	unprognostic (6.10e-2)	unprognostic (2.46e-1)	unprognostic (6.69e-5)	unprognostic (8.54e-2)	unprognostic (4.56e-2)	unprognostic (3.30e-2)	unprognostic (1.06e-2)	unprognostic (6.77e-2)	unprognostic (1.32e-1)	unprognostic (1.00e-3)	unprognostic (3.27e-1)	unprognostic (4.51e-6)	unprognostic (1.02e-2)	unprognostic (1.42e-1)	unprognostic (1.94e-3)	unprognostic (4.66e-3)	Oligodendrocytes
FAM124A	FLJ30707	ENSG00000150510	Family with sequence similarity 124 member A	Q86V42	13	51222334-51284239	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 59.1;choroid plexus: 26.7;retina: 25.7	Cell type enriched	Detected in many	5	Oligodendrocytes: 219.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Neuroblastoma: 6.2	Breast - Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol						Cluster 42: Non-specific - Transcription	Cluster 77: Retina - Visual perception	Cluster 6: BEWO - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm	Cytosol	HPA048182: AB_2680301	unprognostic (3.94e-3)	unprognostic (8.76e-2)	unprognostic (8.05e-2)	unprognostic (1.05e-2)	unprognostic (3.34e-1)	unprognostic (8.37e-2)	unprognostic (2.59e-2)	unprognostic (2.08e-3)	unprognostic (1.52e-1)	unprognostic (1.14e-1)	unprognostic (2.43e-2)	unprognostic (2.03e-1)	unprognostic (1.24e-1)	unprognostic (7.38e-3)	unprognostic (4.51e-2)	unprognostic (4.54e-3)	unprognostic (1.05e-2)	Oligodendrocytes
CNDP1	CN1, CPGL2, HsT2308, MGC10825	ENSG00000150656	Carnosine dipeptidase 1	Q96KN2	18	74534500-74587212	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 85.6	Cell type enriched	Detected in some	11	Oligodendrocytes: 341.4	Cancer enhanced	Detected in some		glioma: 4.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		skin cancer: 1.1	Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Sebaceous gland cells	Not detected	Not detected			Low region specificity	Detected in all			HPA008933, HPA073283	Enhanced				Secreted to blood				2100000000		Cluster 70: Brain - Nervous system development	Cluster 16: Skin cancer - Melanocyte processes	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA008933: AB_1847033, HPA073283: 	unprognostic (7.43e-3)	unprognostic (6.00e-2)	unprognostic (8.55e-3)	unprognostic (3.93e-1)	unprognostic (1.32e-1)	unprognostic (2.17e-2)	unprognostic (8.04e-3)	unprognostic (1.12e-2)	unprognostic (2.81e-1)	unprognostic (1.16e-1)	unprognostic (1.16e-1)	unprognostic (1.66e-1)	unprognostic (6.90e-3)	unprognostic (1.14e-1)	unprognostic (3.30e-2)	unprognostic (1.33e-1)	unprognostic (1.28e-1)	Oligodendrocytes
PIP4K2A	PIP5K2A, PIP5KIIA, PIP5KIIalpha	ENSG00000150867	Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	P48426	10	22534854-22714578	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	brain: 498.1	Cell type enriched	Detected in many	5	Oligodendrocytes: 1496.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA065440, HPA068771	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol					4900000	Cluster 36: GdT-cells - Adaptive immune response	Cluster 70: Brain - Nervous system development	Cluster 64: Lymphoma - Humoral immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus	Plasma membrane, Cytosol	HPA065440: AB_2685490, HPA068771: AB_2686030	unprognostic (1.11e-1)	unprognostic (2.71e-3)	unprognostic (1.57e-3)	unprognostic (4.20e-3)	unprognostic (1.55e-1)	unprognostic (8.80e-3)	unprognostic (1.56e-3)	unprognostic (7.32e-2)	unprognostic (1.68e-1)	unprognostic (7.08e-2)	unprognostic (1.29e-1)	unprognostic (1.21e-1)	prognostic unfavorable (1.46e-4)	unprognostic (1.52e-3)	unprognostic (2.51e-1)	unprognostic (1.38e-1)	unprognostic (7.92e-3)	Oligodendrocytes
C10orf90	bA422P15.2, FATS, FLJ32938	ENSG00000154493	Chromosome 10 open reading frame 90	Q96M02	10	126424997-126798708	Predicted intracellular proteins	Ubl conjugation pathway	Transferase	Tumor suppressor	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	10	brain: 112.1	Cell type enriched	Detected in some	4	Oligodendrocytes: 773.5	Cancer enriched	Detected in some	5	melanoma: 4.7	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	12	skin cancer: 45.2	Adipose visceral - Adipocytes (Visceral), Skin - Eccrine sweat gland cells, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038648, HPA075229	Approved		Approved	Nucleoplasm,Plasma membrane,Cytosol						Cluster 16: MAIT-cells - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 16: Skin cancer - Melanocyte processes	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane, Cytosol	Nucleoplasm	HPA038648: AB_10672721, HPA075229: 	unprognostic (1.21e-2)	unprognostic (3.34e-1)	unprognostic (7.50e-2)	unprognostic (2.05e-2)	unprognostic (1.66e-1)	unprognostic (9.30e-2)	unprognostic (1.98e-3)	unprognostic (5.06e-2)	unprognostic (9.34e-3)	unprognostic (3.73e-2)	unprognostic (9.52e-2)	unprognostic (1.22e-1)	unprognostic (5.06e-11)	unprognostic (2.69e-3)	unprognostic (9.91e-3)	unprognostic (1.26e-1)	unprognostic (2.88e-1)	Oligodendrocytes
PDE1C	Hcam3	ENSG00000154678	Phosphodiesterase 1C	Q14123	7	31751179-32428131	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins		Calmodulin-binding, Hydrolase	Deafness, Disease variant, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	brain: 68.9;heart muscle: 58.5	Cell type enriched	Detected in many	5	Oligodendrocytes: 1011.4	Cancer enhanced	Detected in some		glioma: 1.7	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Brain cancer: 48.0	Breast - Breast myoepithelial cells, Heart muscle - Cardiomyocytes, Kidney - Intercalated cells, Prostate - Fibroblasts, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052375			Approved	Nucleoplasm							Cluster 44: Heart - Cardiac muscle contraction	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm		HPA052375: AB_2681802	unprognostic (1.29e-2)	unprognostic (2.20e-5)	unprognostic (1.68e-2)	unprognostic (1.20e-3)	unprognostic (2.29e-1)	unprognostic (5.65e-2)	unprognostic (4.06e-3)	unprognostic (2.75e-1)	unprognostic (6.79e-3)	unprognostic (6.49e-2)	unprognostic (3.88e-5)	unprognostic (7.03e-2)	unprognostic (3.09e-3)	unprognostic (5.76e-2)	unprognostic (5.80e-2)	unprognostic (1.49e-1)	unprognostic (1.06e-3)	Oligodendrocytes
PIEZO2	C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771	ENSG00000154864	Piezo type mechanosensitive ion channel component 2	Q9H5I5	18	10666483-11149569	Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Sensory transduction, Transport	Ion channel	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 58.3	Cell type enriched	Detected in some	6	Oligodendrocytes: 377.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Breast - Fibroblasts, Colon - Enteric glia cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - Fibroblasts	Not detected	Not detected			Low region specificity	Detected in some			HPA015986, HPA031974, HPA040616	Approved		Approved	Plasma membrane,Cytosol							Cluster 70: Brain - Nervous system development	Cluster 7: Neuronal cell lines - Stereocilium	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane, Cytosol		HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043	unprognostic (1.36e-1)	unprognostic (1.92e-1)	unprognostic (9.21e-2)	unprognostic (2.53e-2)	unprognostic (7.84e-2)	unprognostic (3.16e-2)	unprognostic (3.87e-2)	unprognostic (4.34e-3)	unprognostic (6.55e-2)	unprognostic (3.89e-2)	unprognostic (6.06e-2)	unprognostic (2.23e-1)	prognostic unfavorable (9.57e-7)	unprognostic (1.12e-3)	unprognostic (1.09e-1)	unprognostic (9.04e-2)	unprognostic (1.83e-2)	Oligodendrocytes
SLC5A11	KST1, SGLT6, SMIT2	ENSG00000158865	Solute carrier family 5 member 11	Q8WWX8	16	24845841-24911628	Metabolic proteins, Predicted membrane proteins, Transporters	Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 43.9	Cell type enriched	Detected in some	18	Oligodendrocytes: 639.9	Cancer enhanced	Detected in some		glioma: 1.1	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 1.1	Kidney - Proximal tubular cells	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol							Cluster 70: Brain - Nervous system development	Cluster 50: L-1236 & L-428 - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm	Cytosol	HPA035331: AB_10601489	unprognostic (2.57e-1)	unprognostic (7.90e-3)	unprognostic (1.34e-2)	unprognostic (2.65e-2)	unprognostic (2.00e-2)	unprognostic (1.08e-1)	unprognostic (1.27e-2)	unprognostic (9.90e-2)	unprognostic (8.08e-2)	unprognostic (2.85e-1)	unprognostic (2.85e-3)	unprognostic (6.68e-2)	unprognostic (1.17e-2)	unprognostic (1.59e-1)	unprognostic (1.58e-1)	unprognostic (8.07e-2)	unprognostic (1.45e-3)	Oligodendrocytes
SLC22A15	FLIPT1	ENSG00000163393	Solute carrier family 22 member 15	Q8IZD6	1	115976513-116070054	Metabolic proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 30.6;brain: 31.8	Cell type enriched	Detected in many	4	Oligodendrocytes: 236.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		neutrophil: 1.3;non-classical monocyte: 1.2	Group enriched	Detected in many	8	granulocytes: 1.3;monocytes: 1.2	Low cancer specificity	Detected in many			Skin - Keratinocyte (other)	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA019785	Uncertain									Cluster 14: Monocytes - Unknown function	Cluster 76: Brain & Bone marrow - Chromatin organization	Cluster 66: Myeloid cells - Innate immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA019785: AB_1857011	unprognostic (3.81e-1)	unprognostic (1.11e-2)	unprognostic (7.65e-3)	unprognostic (1.01e-3)	unprognostic (5.62e-2)	unprognostic (5.22e-2)	unprognostic (5.85e-5)	unprognostic (8.91e-3)	unprognostic (1.81e-1)	unprognostic (4.97e-2)	unprognostic (5.15e-2)	unprognostic (9.06e-2)	unprognostic (7.29e-3)	unprognostic (8.78e-3)	unprognostic (3.44e-1)	unprognostic (9.97e-4)	unprognostic (1.30e-1)	Oligodendrocytes
TMEM144	FLJ11155	ENSG00000164124	Transmembrane protein 144	Q7Z5S9	4	158201604-158255416	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	14	brain: 418.0	Cell type enriched	Detected in many	4	Oligodendrocytes: 938.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		myeloid DC: 2.1;plasmacytoid DC: 2.2	Group enriched	Detected in many	10	dendritic cells: 2.2;monocytes: 1.4	Low cancer specificity	Detected in many			Testis - Early spermatids, Testis - Late spermatids, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063554			Approved	Mitochondria						Cluster 28: Myeloid DCs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 8: Oligodendrocytes - Myelin sheath organization	Mitochondria		HPA063554: AB_2685039	unprognostic (1.26e-2)	unprognostic (7.05e-2)	unprognostic (2.06e-2)	prognostic favorable (2.89e-4)	unprognostic (2.90e-1)	unprognostic (1.71e-5)	unprognostic (8.27e-2)	unprognostic (3.32e-1)	unprognostic (2.21e-1)	unprognostic (3.33e-2)	prognostic unfavorable (8.48e-4)	unprognostic (9.34e-2)	unprognostic (1.13e-2)	unprognostic (1.35e-1)	unprognostic (9.26e-2)	unprognostic (3.88e-2)	unprognostic (4.05e-2)	Oligodendrocytes
KIF6	C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317	ENSG00000164627	Kinesin family member 6	Q6ZMV9	6	39329990-39725408	Predicted intracellular proteins		Motor protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 18.3;testis: 5.3	Cell type enriched	Detected in some	6	Oligodendrocytes: 208.0	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	4	skin cancer: 9.6	Lung - Respiratory ciliated cells, Testis - Early spermatids	Low region specificity	Detected in many			Region enhanced	Detected in single		midbrain: 1.7	HPA038811, HPA058624	Enhanced		Approved	Nucleoplasm,Centrosome						Cluster 11: Basophils - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization	Centrosome	Nucleoplasm	HPA038811: AB_10795140, HPA058624: AB_2683781	unprognostic (4.94e-2)	unprognostic (3.38e-2)	unprognostic (3.68e-1)	unprognostic (1.02e-2)	unprognostic (1.55e-1)	unprognostic (8.25e-4)	unprognostic (3.12e-3)	unprognostic (1.00e-1)	unprognostic (3.06e-1)	unprognostic (3.48e-2)	unprognostic (9.12e-4)	unprognostic (1.08e-1)	unprognostic (3.07e-2)	unprognostic (3.10e-2)	unprognostic (5.09e-2)	unprognostic (3.92e-2)	unprognostic (1.99e-1)	Oligodendrocytes
USP54	bA137L10.3, bA137L10.4, C10orf29, FLJ37318	ENSG00000166348	Ubiquitin specific peptidase 54	Q70EL1	10	73497538-73625994	Enzymes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 134.8	Cell type enriched	Detected in many	4	Oligodendrocytes: 449.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in all			Lung - Alveolar cells type 2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047663, HPA063665	Approved		Approved	Mitochondria						Cluster 27: Non-specific - Gene expression	Cluster 70: Brain - Nervous system development	Cluster 24: Prostate cancer - Lipid metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Mitochondria		HPA047663: AB_2680116, HPA063665: 	unprognostic (2.46e-2)	unprognostic (1.67e-1)	unprognostic (3.17e-2)	unprognostic (1.89e-2)	unprognostic (2.48e-2)	unprognostic (4.89e-3)	unprognostic (6.63e-4)	prognostic favorable (7.00e-4)	unprognostic (6.24e-2)	unprognostic (4.35e-2)	unprognostic (8.91e-3)	unprognostic (3.49e-1)	unprognostic (1.95e-3)	unprognostic (8.18e-2)	unprognostic (6.88e-2)	unprognostic (1.65e-2)	unprognostic (1.31e-1)	Oligodendrocytes
CERCAM	CEECAM1, GLT25D3	ENSG00000167123	Cerebral endothelial cell adhesion molecule	Q5T4B2	9	128411751-128437351	Metabolic proteins, Predicted intracellular proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 551.5	Cell type enriched	Detected in many	8	Oligodendrocytes: 591.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Stomach - Fibroblasts, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021657, HPA051595	Uncertain		Approved	Nucleoplasm,Nucleoli,Cell Junctions	Intracellular and membrane					Cluster 36: GdT-cells - Adaptive immune response	Cluster 70: Brain - Nervous system development	Cluster 20: Connective tissue cells - ECM organization	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm, Nucleoli	Cell Junctions	HPA021657: AB_1846507, HPA051595: AB_2681545	unprognostic (2.87e-2)	unprognostic (1.37e-3)	unprognostic (1.89e-3)	unprognostic (2.19e-1)	unprognostic (4.68e-3)	unprognostic (7.79e-3)	unprognostic (3.29e-3)	unprognostic (5.68e-2)	unprognostic (1.00e-1)	prognostic unfavorable (5.22e-4)	unprognostic (1.59e-1)	unprognostic (5.93e-2)	prognostic unfavorable (3.33e-16)	unprognostic (1.34e-2)	unprognostic (1.04e-1)	unprognostic (6.05e-3)	prognostic unfavorable (3.30e-5)	Oligodendrocytes
PXK	FLJ20335, Slob	ENSG00000168297	PX domain containing serine/threonine kinase like	Q7Z7A4	3	58332880-58426127	Enzymes, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	brain: 320.5	Cell type enriched	Detected in all	9	Oligodendrocytes: 691.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Cancer enhanced	Detected in all		Leukemia: 72.0	Prostate - Fibroblasts, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024068	Supported		Supported	Plasma membrane,Centriolar satellite,Cytosol						Cluster 14: Monocytes - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytosol	Plasma membrane, Centriolar satellite	HPA024068: AB_1855967	unprognostic (2.98e-2)	unprognostic (3.29e-1)	unprognostic (2.71e-3)	unprognostic (1.61e-1)	unprognostic (2.40e-1)	unprognostic (6.62e-3)	unprognostic (5.03e-3)	prognostic favorable (5.68e-4)	unprognostic (3.90e-1)	unprognostic (8.09e-2)	unprognostic (3.48e-2)	unprognostic (1.21e-1)	unprognostic (1.38e-3)	unprognostic (2.14e-1)	unprognostic (1.06e-1)	unprognostic (1.03e-1)	unprognostic (2.86e-2)	Oligodendrocytes
MOBP		ENSG00000168314	Myelin associated oligodendrocyte basic protein	Q13875	3	39467198-39529479	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	brain: 918.8	Cell type enriched	Detected in some	13	Oligodendrocytes: 1517.1	Cancer enriched	Detected in single	63	glioma: 4.9	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in all							HPA035152	Enhanced		Supported	Cytoplasmic bodies							Cluster 70: Brain - Nervous system development	Cluster 2: DU4475 - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytoplasmic bodies		HPA035152: AB_10603020	unprognostic (1.76e-2)	unprognostic (2.34e-1)	unprognostic (3.53e-2)	unprognostic (7.35e-2)	unprognostic (5.67e-2)	unprognostic (3.60e-2)	unprognostic (7.47e-2)	unprognostic (2.82e-1)	unprognostic (7.49e-2)	unprognostic (1.28e-1)	unprognostic (1.01e-1)	unprognostic (2.07e-1)	unprognostic (2.04e-5)	unprognostic (2.28e-1)	unprognostic (8.98e-2)	unprognostic (1.49e-1)	unprognostic (1.41e-2)	Oligodendrocytes
CARNS1	ATPGD1, KIAA1394	ENSG00000172508	Carnosine synthase 1	A5YM72	11	67414968-67425607	Enzymes, Metabolic proteins, Predicted intracellular proteins		Ligase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	brain: 278.3;skeletal muscle: 75.5	Cell type enriched	Detected in some	14	Oligodendrocytes: 422.8	Group enriched	Detected in many	5	glioma: 4.1;thyroid cancer: 10.3	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in single			Not detected	Not detected			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes	Low region specificity	Detected in all			Low region specificity	Detected in single			HPA038569	Enhanced				Intracellular and membrane					Cluster 36: GdT-cells - Adaptive immune response	Cluster 70: Brain - Nervous system development	Cluster 10: Ovarian & Endometrial cancers - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA038569: AB_2676089	unprognostic (1.07e-4)	unprognostic (4.33e-3)	unprognostic (2.00e-2)	unprognostic (6.15e-2)	unprognostic (9.45e-2)	unprognostic (1.05e-1)	unprognostic (7.28e-2)	unprognostic (7.54e-3)	unprognostic (1.29e-1)	unprognostic (1.82e-1)	unprognostic (5.19e-3)	unprognostic (1.00e-1)	unprognostic (6.14e-6)	unprognostic (3.44e-2)	unprognostic (1.33e-1)	unprognostic (3.83e-3)	unprognostic (8.33e-2)	Oligodendrocytes
UGT8	CGT	ENSG00000174607	UDP glycosyltransferase 8	Q16880	4	114598770-114678225	Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid metabolism, Sphingolipid metabolism	Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 266.4	Cell type enriched	Detected in many	8	Oligodendrocytes: 775.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	10	memory B-cell: 6.9;naive B-cell: 10.7	Lineage enriched	Detected in single	12	B-cells: 10.7	Low cancer specificity	Detected in all			Colon - Colon enterocytes, Skin - Eccrine sweat gland cells, Testis - Spermatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA014405, HPA065785	Enhanced		Approved	Mitochondria		No	No			Cluster 19: B-cells - Humoral immune response	Cluster 70: Brain - Nervous system development	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 8: Oligodendrocytes - Myelin sheath organization	Mitochondria		HPA014405: AB_1858606, HPA065785: AB_2685559	unprognostic (7.38e-3)	unprognostic (2.07e-1)	unprognostic (1.25e-2)	unprognostic (2.38e-1)	unprognostic (1.63e-1)	unprognostic (1.63e-2)	unprognostic (1.16e-2)	unprognostic (2.38e-1)	unprognostic (7.78e-2)	unprognostic (1.56e-3)	unprognostic (4.49e-2)	unprognostic (2.76e-1)	prognostic favorable (8.55e-5)	unprognostic (2.80e-1)	unprognostic (1.78e-2)	unprognostic (7.53e-2)	unprognostic (1.49e-1)	Oligodendrocytes
PRR18	MGC35308	ENSG00000176381	Proline rich 18	Q8N4B5	6	166305300-166308448	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	13	brain: 127.0	Cell type enriched	Detected in some	4	Oligodendrocytes: 25.8	Group enriched	Detected in some	5	glioma: 3.1;liver cancer: 1.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - Respiratory ciliated cells	Low region specificity	Detected in all							HPA077250	Enhanced										Cluster 70: Brain - Nervous system development	Cluster 9: Lymphoid cancers - Immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA077250: AB_2732336	unprognostic (2.91e-1)	unprognostic (7.18e-2)	unprognostic (1.76e-1)	unprognostic (2.39e-2)	unprognostic (1.44e-1)	unprognostic (9.65e-2)	unprognostic (5.60e-3)	unprognostic (1.25e-1)	unprognostic (1.10e-1)	unprognostic (3.16e-2)	unprognostic (2.44e-3)	unprognostic (4.79e-3)	unprognostic (2.43e-1)	unprognostic (3.35e-3)	unprognostic (9.49e-2)	unprognostic (9.58e-2)	unprognostic (1.07e-1)	Oligodendrocytes
SLCO3A1	OATP-D, OATP3A1, SLC21A11	ENSG00000176463	Solute carrier organic anion transporter family member 3A1	Q9UIG8	15	91853708-92172435	Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 39.5	Cell type enriched	Detected in many	4	Oligodendrocytes: 590.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in many			Skin - Keratinocyte (other), Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA066327	Approved									Cluster 10: Basophils - Unknown function	Cluster 57: Non-specific - Angiogenesis	Cluster 2: DU4475 - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA066327: AB_2732743	unprognostic (1.05e-3)	prognostic favorable (8.61e-4)	unprognostic (5.40e-2)	prognostic unfavorable (6.57e-6)	unprognostic (1.03e-1)	unprognostic (7.39e-2)	unprognostic (2.16e-1)	unprognostic (1.57e-1)	unprognostic (2.52e-1)	unprognostic (1.84e-1)	unprognostic (1.42e-2)	unprognostic (1.49e-2)	unprognostic (2.64e-2)	unprognostic (3.06e-2)	unprognostic (1.86e-1)	unprognostic (7.17e-2)	unprognostic (1.62e-2)	Oligodendrocytes
NT5DC1	dJ486I3.1, MGC24302, NT5C2L1	ENSG00000178425	5'-nucleotidase domain containing 1	Q5TFE4	6	116100851-116249497	Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		choroid plexus: 117.6	Cell type enriched	Detected in all	4	Oligodendrocytes: 405.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Liver - Hepatocytes, Prostate - Prostate glandular cells, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030352, HPA079264	Uncertain		Approved	Nucleoplasm,Cytosol					140000	Cluster 37: B-cells - Transcription	Cluster 88: Choroid plexus - Transmembrane transport	Cluster 15: Non-specific - Protein binding	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm	Cytosol	HPA030352: AB_2154066, HPA079264: 	unprognostic (1.30e-1)	unprognostic (2.92e-1)	prognostic favorable (2.61e-4)	unprognostic (1.14e-1)	unprognostic (3.13e-2)	unprognostic (7.80e-2)	unprognostic (3.46e-2)	unprognostic (1.10e-1)	unprognostic (2.32e-1)	unprognostic (2.31e-2)	unprognostic (4.61e-1)	unprognostic (1.47e-1)	prognostic favorable (7.49e-7)	unprognostic (1.41e-1)	unprognostic (8.53e-2)	unprognostic (2.79e-1)	unprognostic (9.63e-2)	Oligodendrocytes
TMTC2	DKFZp762A217	ENSG00000179104	Transmembrane O-mannosyltransferase targeting cadherins 2	Q8N394	12	82686880-83134870	Enzymes, Predicted membrane proteins		Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 60.8	Cell type enriched	Detected in many	5	Oligodendrocytes: 2031.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in all		skin cancer: 28.0	Skeletal muscle - Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026954, HPA026955	Uncertain		Approved	Plasma membrane,Actin filaments		No	No			Cluster 37: B-cells - Transcription	Cluster 70: Brain - Nervous system development	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane	Actin filaments	HPA026954: AB_2256025, HPA026955: AB_10602282	unprognostic (1.56e-1)	unprognostic (5.62e-2)	unprognostic (9.61e-2)	unprognostic (7.38e-2)	unprognostic (2.60e-2)	unprognostic (3.66e-2)	unprognostic (1.05e-2)	unprognostic (1.58e-1)	unprognostic (1.25e-1)	unprognostic (7.16e-2)	unprognostic (1.73e-3)	unprognostic (5.06e-2)	prognostic favorable (2.84e-5)	unprognostic (1.10e-1)	unprognostic (1.60e-1)	unprognostic (2.06e-2)	unprognostic (8.06e-2)	Oligodendrocytes
OR9A2		ENSG00000179468	Olfactory receptor family 9 subfamily A member 2	Q8NGT5	7	143026158-143027195	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enriched	Detected in single	53	brain: 5.2	Cell type enriched	Detected in some	38	Oligodendrocytes: 72.3	Not detected	Not detected			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected																		Cluster 70: Brain - Nervous system development		Cluster 8: Oligodendrocytes - Myelin sheath organization																					Oligodendrocytes
MAP6D1	FLJ12748, SL21	ENSG00000180834	MAP6 domain containing 1	Q9H9H5	3	183815922-183825594	Predicted intracellular proteins		Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 102.6;choroid plexus: 24.9;skeletal muscle: 26.9	Cell type enriched	Detected in some	13	Oligodendrocytes: 95.6	Cancer enhanced	Detected in many		glioma: 9.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Skeletal muscle - Skeletal myocytes, Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037991	Enhanced	Supported	Approved	Cytosol							Cluster 70: Brain - Nervous system development	Cluster 65: Breast cancer - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Cytosol		HPA037991: AB_10672503	unprognostic (9.23e-3)	unprognostic (2.70e-1)	unprognostic (1.65e-1)	unprognostic (1.27e-3)	unprognostic (1.32e-1)	unprognostic (3.67e-2)	unprognostic (1.21e-1)	unprognostic (1.13e-1)	unprognostic (2.42e-1)	unprognostic (1.28e-2)	unprognostic (5.36e-2)	prognostic unfavorable (3.37e-4)	unprognostic (8.81e-12)	unprognostic (1.08e-1)	unprognostic (2.96e-3)	unprognostic (1.86e-1)	unprognostic (5.72e-2)	Oligodendrocytes
GPR62		ENSG00000180929	G protein-coupled receptor 62	Q9BZJ7	3	51955381-51957499	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 34.9	Cell type enriched	Detected in some	5	Oligodendrocytes: 17.7	Cancer enhanced	Detected in single		glioma: 1.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Low region specificity	Detected in all			Low region specificity	Detected in all														Cluster 70: Brain - Nervous system development	Cluster 47: Retina - Visual perception	Cluster 8: Oligodendrocytes - Myelin sheath organization				unprognostic (9.56e-3)	unprognostic (3.32e-3)	unprognostic (2.21e-1)	unprognostic (6.38e-2)	unprognostic (7.98e-2)	unprognostic (1.66e-2)	unprognostic (9.02e-2)	unprognostic (6.49e-2)	unprognostic (2.03e-2)	unprognostic (6.17e-2)	unprognostic (3.05e-2)	unprognostic (1.26e-1)	unprognostic (1.82e-5)	unprognostic (3.64e-2)	unprognostic (2.45e-1)	unprognostic (1.16e-2)	unprognostic (1.77e-2)	Oligodendrocytes
UNC5C		ENSG00000182168	Unc-5 netrin receptor C	O95185	4	95162504-95549206	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Apoptosis	Developmental protein, Receptor	Alzheimer disease, Amyloidosis, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 40.5	Cell type enriched	Detected in many	4	Oligodendrocytes: 1962.4	Cancer enriched	Detected in many	4	thyroid cancer: 6.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	4	Neuroblastoma: 53.5	Liver - Hepatic stellate cells, Skin - Eccrine sweat gland cells, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all												310000		Cluster 70: Brain - Nervous system development	Cluster 21: Neuroblastoma - Neuronal signaling	Cluster 32: Neurons - Synaptic function				unprognostic (1.55e-1)	unprognostic (2.72e-1)	unprognostic (1.35e-2)	unprognostic (8.45e-2)	unprognostic (3.03e-1)	unprognostic (3.20e-1)	unprognostic (3.48e-1)	unprognostic (3.40e-1)	unprognostic (3.12e-1)	unprognostic (1.11e-3)	unprognostic (1.68e-1)	unprognostic (1.39e-1)	unprognostic (2.70e-5)	unprognostic (1.25e-2)	unprognostic (1.16e-1)	unprognostic (1.86e-1)	unprognostic (3.62e-4)	Oligodendrocytes
CTNNA3	MGC26194, VR22	ENSG00000183230	Catenin alpha 3	Q9UI47	10	65912523-67696195	Disease related genes, Predicted intracellular proteins	Cell adhesion		Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	brain: 176.3	Cell type enriched	Detected in some	12	Oligodendrocytes: 3827.5	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061818	Enhanced									Cluster 47: Plasmacytoid DCs - Protein folding	Cluster 70: Brain - Nervous system development	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA061818: AB_2684618	unprognostic (2.19e-1)	unprognostic (1.57e-1)	unprognostic (8.64e-4)	unprognostic (8.13e-3)	unprognostic (6.43e-3)	unprognostic (9.90e-2)	unprognostic (2.60e-4)	unprognostic (8.27e-2)	unprognostic (5.10e-2)	unprognostic (2.55e-1)	unprognostic (9.09e-3)	unprognostic (1.15e-1)	unprognostic (2.67e-3)	unprognostic (7.93e-5)	unprognostic (6.43e-2)	unprognostic (1.52e-2)	unprognostic (1.24e-1)	Oligodendrocytes
ACP7	FLJ16165, PAPL, PAPL1	ENSG00000183760	Acid phosphatase 7, tartrate resistant (putative)	Q6ZNF0	19	39083913-39111493	Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	6	brain: 6.6;lymphoid tissue: 2.6;skin 1: 6.0	Cell type enriched	Detected in some	5	Oligodendrocytes: 10.2	Group enriched	Detected in some	5	cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Skin - Keratinocyte (granular)	Low region specificity	Detected in many			Not detected	Not detected			HPA042613	Uncertain				Secreted - unknown location						Cluster 27: Brain & Skin - Unknown function	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA042613: AB_10963214	unprognostic (6.35e-2)	unprognostic (1.97e-1)	unprognostic (1.48e-1)	unprognostic (6.74e-3)	unprognostic (1.92e-3)	unprognostic (1.41e-1)	unprognostic (3.41e-1)	unprognostic (4.94e-3)	unprognostic (2.66e-1)	unprognostic (2.15e-1)	unprognostic (1.50e-1)	unprognostic (9.81e-2)	unprognostic (1.51e-5)	unprognostic (4.36e-3)	unprognostic (5.08e-2)	unprognostic (2.31e-2)	unprognostic (2.42e-1)	Oligodendrocytes
CNTN2	AXT, TAG-1, TAX, TAX1	ENSG00000184144	Contactin 2	Q02246	1	205042937-205078289	Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters	Cell adhesion		Epilepsy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	brain: 248.9	Cell type enriched	Detected in many	12	Oligodendrocytes: 316.7	Cancer enriched	Detected in some	9	glioma: 6.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	Neuroblastoma: 5.6	Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001397, HPA012497	Approved				Secreted in brain				58000		Cluster 70: Brain - Nervous system development	Cluster 7: Neuronal cell lines - Stereocilium	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA001397: AB_1847146, HPA012497: AB_1847147	unprognostic (1.90e-1)	unprognostic (1.86e-1)	unprognostic (2.87e-2)	unprognostic (4.52e-3)	unprognostic (2.98e-2)	unprognostic (5.96e-2)	unprognostic (3.25e-1)	unprognostic (1.43e-2)	unprognostic (8.56e-2)	unprognostic (2.40e-1)	unprognostic (3.44e-3)	unprognostic (5.62e-2)	unprognostic (1.73e-7)	unprognostic (9.82e-3)	unprognostic (1.19e-1)	unprognostic (3.35e-2)	unprognostic (3.07e-2)	Oligodendrocytes
CHRM5		ENSG00000184984	Cholinergic receptor muscarinic 5	P08912	15	33968497-34067458	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	brain: 18.8	Cell type enriched	Detected in some	7	Oligodendrocytes: 168.4	Not detected	Not detected			Low region specificity	Detected in all			Immune cell enhanced	Detected in single		neutrophil: 1.4	Lineage enriched	Detected in single	5	granulocytes: 1.4	Low cancer specificity	Detected in single			Testis - Early spermatids, Testis - Late spermatids	Region enhanced	Detected in many		hypothalamus: 13.2	Low region specificity	Detected in many			HPA013172	Uncertain									Cluster 1: Neutrophils - Mixed function	Cluster 70: Brain - Nervous system development	Cluster 62: Granulocytes - Innate immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA013172: AB_1854212	unprognostic (8.19e-2)	unprognostic (2.13e-1)	unprognostic (7.67e-2)	unprognostic (4.32e-1)	unprognostic (3.05e-3)	unprognostic (2.77e-1)	unprognostic (2.49e-2)	unprognostic (2.79e-1)	unprognostic (3.02e-1)	unprognostic (1.27e-2)	unprognostic (4.61e-4)	unprognostic (7.95e-2)	unprognostic (1.33e-6)	unprognostic (1.42e-1)	unprognostic (4.53e-2)	unprognostic (1.38e-1)	unprognostic (9.07e-2)	Oligodendrocytes
GLDN	CLOM, COLM, colmedin, CRG-L2, UNC-122	ENSG00000186417	Gliomedin	Q6ZMI3	15	51341655-51408005	Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Differentiation, Neurogenesis	Developmental protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 84.8	Cell type enriched	Detected in many	4	Oligodendrocytes: 482.2	Cancer enhanced	Detected in many		glioma: 4.3	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Heart muscle - Cardiomyocytes, Thyroid - Smooth muscle cells	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA050873, HPA059441	Uncertain		Supported	Vesicles,Plasma membrane	Secreted to extracellular matrix				410000		Cluster 70: Brain - Nervous system development	Cluster 61: Liver - Metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles, Plasma membrane		HPA050873: , HPA059441: AB_2684018	unprognostic (5.04e-2)	unprognostic (2.57e-2)	unprognostic (5.15e-5)	unprognostic (3.21e-3)	unprognostic (2.82e-2)	unprognostic (2.33e-1)	unprognostic (2.07e-4)	unprognostic (2.02e-1)	unprognostic (1.22e-1)	unprognostic (3.30e-2)	unprognostic (3.15e-1)	unprognostic (2.14e-2)	unprognostic (9.89e-2)	unprognostic (1.60e-2)	unprognostic (2.20e-1)	unprognostic (3.80e-3)	unprognostic (1.37e-1)	Oligodendrocytes
RNF220	C1orf164, FLJ10597	ENSG00000187147	Ring finger protein 220	Q5VTB9	1	44405194-44651724	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 121.3	Cell type enriched	Detected in all	6	Oligodendrocytes: 2017.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027577, HPA027578	Approved		Approved	Nucleoplasm,Cytosol	Intracellular and membrane					Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 66: Myeloid cells - Innate immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Nucleoplasm	Cytosol	HPA027577: AB_2672339, HPA027578: AB_10601482	unprognostic (3.12e-2)	unprognostic (1.24e-1)	unprognostic (3.49e-2)	unprognostic (2.56e-1)	unprognostic (2.94e-2)	unprognostic (6.96e-3)	prognostic unfavorable (2.35e-6)	unprognostic (1.55e-1)	unprognostic (8.47e-2)	unprognostic (2.13e-1)	unprognostic (2.14e-3)	unprognostic (2.96e-2)	prognostic unfavorable (5.12e-4)	unprognostic (1.51e-2)	unprognostic (1.98e-1)	unprognostic (1.37e-3)	unprognostic (6.46e-2)	Oligodendrocytes
SHTN1	KIAA1598, shootin-1, shootin1	ENSG00000187164	Shootin 1	A0MZ66	10	116881477-117126586	Predicted intracellular proteins		Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	brain: 128.1	Cell type enriched	Detected in many	4	Oligodendrocytes: 980.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	31	classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9	Group enriched	Detected in many	42	dendritic cells: 19.3;monocytes: 19.7	Low cancer specificity	Detected in all			Adipose subcutaneous - Macrophages, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037942, HPA037943, HPA075224	Enhanced	Approved	Approved	Plasma membrane,Cytosol						Cluster 25: Monocytes - Inflammatory response	Cluster 70: Brain - Nervous system development	Cluster 61: Liver - Metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane, Cytosol		HPA037942: AB_2675748, HPA037943: AB_10671637, HPA075224: 	unprognostic (1.00e-1)	unprognostic (2.50e-2)	unprognostic (6.77e-3)	unprognostic (2.81e-1)	unprognostic (7.85e-2)	unprognostic (1.61e-1)	unprognostic (2.42e-2)	unprognostic (1.03e-1)	unprognostic (2.56e-1)	unprognostic (1.35e-1)	unprognostic (2.49e-1)	prognostic unfavorable (5.07e-4)	unprognostic (2.17e-2)	unprognostic (1.48e-1)	unprognostic (2.47e-1)	unprognostic (1.85e-1)	prognostic unfavorable (5.08e-6)	Oligodendrocytes
COL4A5	ASLN, ATS	ENSG00000188153	Collagen type IV alpha 5 chain	P29400	X	108439838-108697545	Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins			Alport syndrome, Cancer-related genes, Deafness, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 102.9	Cell type enriched	Detected in many	9	Oligodendrocytes: 673.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in all		testis cancer: 65.6	Adipose subcutaneous - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077177			Approved	Vesicles,Plasma membrane	Secreted to extracellular matrix						Cluster 57: Non-specific - Angiogenesis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane	Vesicles	HPA077177: 	unprognostic (2.58e-2)	unprognostic (2.57e-2)	unprognostic (3.64e-2)	unprognostic (3.98e-2)	unprognostic (1.11e-1)	unprognostic (1.61e-1)	unprognostic (1.97e-2)	unprognostic (7.27e-2)	unprognostic (2.70e-1)	unprognostic (2.20e-1)	unprognostic (1.60e-1)	unprognostic (1.26e-1)	prognostic unfavorable (2.41e-5)	unprognostic (2.10e-3)	unprognostic (1.70e-1)	unprognostic (2.61e-2)	unprognostic (1.06e-1)	Oligodendrocytes
DPYD	DPD	ENSG00000188641	Dihydropyrimidine dehydrogenase	Q12882	1	97077743-97995000	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins		Oxidoreductase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 68.5	Cell type enriched	Detected in many	6	Oligodendrocytes: 1616.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in all			Low cancer specificity	Detected in many			Kidney - Fibroblasts, Liver - Hepatocytes, Liver - Hepatocytes, Prostate - Fibroblasts, Skin - Endothelial cells, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB033241, HPA045210	Uncertain								1600000	Cluster 25: Monocytes - Inflammatory response	Cluster 85: Liver - Metabolism	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 8: Oligodendrocytes - Myelin sheath organization			CAB033241: AB_2094323, HPA045210: AB_2679256	unprognostic (2.33e-2)	unprognostic (1.69e-1)	unprognostic (9.82e-3)	unprognostic (1.04e-1)	unprognostic (1.13e-2)	unprognostic (8.81e-2)	unprognostic (2.86e-1)	unprognostic (3.05e-1)	unprognostic (1.56e-1)	unprognostic (9.29e-2)	prognostic unfavorable (6.27e-4)	unprognostic (6.54e-2)	unprognostic (5.32e-2)	unprognostic (1.43e-1)	unprognostic (3.43e-2)	unprognostic (3.71e-1)	unprognostic (2.25e-1)	Oligodendrocytes
TMEM63A	KIAA0792	ENSG00000196187	Transmembrane protein 63A	O94886	1	225845536-225882380	Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel	Disease variant, Leukodystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	brain: 365.5;salivary gland: 121.1	Cell type enriched	Detected in many	4	Oligodendrocytes: 305.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Prostate - Prostate basal glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA066504, HPA066936, HPA068918			Enhanced	Vesicles,Centriolar satellite						Cluster 20: T-cells - T-cell receptor	Cluster 70: Brain - Nervous system development	Cluster 65: Breast cancer - Unknown function	Cluster 8: Oligodendrocytes - Myelin sheath organization	Vesicles, Centriolar satellite		HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057	unprognostic (5.31e-2)	unprognostic (3.46e-2)	unprognostic (2.14e-2)	prognostic favorable (8.79e-4)	unprognostic (2.05e-1)	unprognostic (7.16e-3)	unprognostic (2.52e-2)	unprognostic (1.76e-2)	unprognostic (2.57e-1)	unprognostic (1.27e-1)	unprognostic (6.55e-2)	unprognostic (1.59e-1)	unprognostic (1.19e-1)	unprognostic (3.14e-2)	unprognostic (1.62e-1)	unprognostic (3.35e-1)	unprognostic (2.92e-2)	Oligodendrocytes
MVB12B	C9orf28, FAM125B, FLJ00001	ENSG00000196814	Multivesicular body subunit 12B	Q9H7P6	9	126326829-126507041	Predicted intracellular proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 99.3	Cell type enriched	Detected in many	6	Oligodendrocytes: 477.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		MAIT T-cell: 2.5	Low lineage specificity	Detected in many			Low cancer specificity	Detected in many				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043683, HPA049383			Approved	Golgi apparatus,Vesicles						Cluster 16: MAIT-cells - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization	Golgi apparatus, Vesicles		HPA043683: AB_2678616, HPA049383: AB_2680737	unprognostic (3.50e-1)	unprognostic (1.12e-1)	unprognostic (6.82e-2)	unprognostic (9.59e-3)	unprognostic (4.77e-2)	unprognostic (1.13e-1)	unprognostic (4.22e-2)	unprognostic (4.45e-3)	unprognostic (4.33e-1)	unprognostic (1.05e-1)	prognostic favorable (7.89e-4)	unprognostic (2.82e-1)	unprognostic (1.66e-3)	unprognostic (3.06e-1)	unprognostic (1.71e-1)	unprognostic (5.79e-2)	unprognostic (1.12e-3)	Oligodendrocytes
OPALIN	HTMP10, TMEM10, TMP10	ENSG00000197430	Oligodendrocytic myelin paranodal and inner loop protein	Q96PE5	10	96343221-96359365	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	654	brain: 166.5;choroid plexus: 47.8	Cell type enriched	Detected in single	298	Oligodendrocytes: 287.4	Cancer enriched	Detected in single	36	glioma: 1.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Region enhanced	Detected in all		white matter: 240.1	Low region specificity	Detected in all			HPA014372	Supported										Cluster 65: Brain - Ion transport	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA014372: AB_2158172					unprognostic (1.18e-1)													Oligodendrocytes
MBP		ENSG00000197971	Myelin basic protein	P02686	18	76978827-77133683	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins			Autoimmune encephalomyelitis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	142	brain: 30812.9;choroid plexus: 9144.9	Cell type enriched	Detected in many	10	Oligodendrocytes: 2733.4	Group enriched	Detected in all	9	glioma: 47.5;melanoma: 20.8	Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Cancer enriched	Detected in many	6	skin cancer: 213.8	Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002300, HPA049222, HPA064368	Enhanced	Supported	Approved	Plasma membrane					54000	Cluster 5: Granulocytes - Unknown function	Cluster 70: Brain - Nervous system development	Cluster 16: Skin cancer - Melanocyte processes	Cluster 8: Oligodendrocytes - Myelin sheath organization	Plasma membrane		CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247	unprognostic (9.36e-2)	unprognostic (7.60e-2)	unprognostic (1.28e-2)	unprognostic (1.22e-1)	unprognostic (6.93e-2)	unprognostic (2.81e-1)	unprognostic (1.14e-1)	unprognostic (3.31e-1)	unprognostic (9.87e-2)	unprognostic (2.90e-2)	unprognostic (5.25e-2)	unprognostic (1.95e-1)	prognostic favorable (4.48e-12)	unprognostic (2.90e-1)	unprognostic (5.99e-2)	unprognostic (1.33e-1)	unprognostic (6.03e-2)	Oligodendrocytes
LPAR1	edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1	ENSG00000198121	Lysophosphatidic acid receptor 1	Q92633	9	110873263-111038458	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 358.4;choroid plexus: 122.2	Cell type enriched	Detected in many	4	Oligodendrocytes: 591.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	classical monocyte: 9.1;eosinophil: 19.0	Group enriched	Detected in many	6	granulocytes: 19.0;monocytes: 9.1	Low cancer specificity	Detected in many			Breast - Fibroblasts, Colon - Enteric glia cells, Heart muscle - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 45: Eosinophils - Innate immune response	Cluster 70: Brain - Nervous system development	Cluster 59: Fibroblasts - Metabolism	Cluster 8: Oligodendrocytes - Myelin sheath organization				unprognostic (1.35e-1)	unprognostic (1.41e-1)	unprognostic (4.79e-2)	unprognostic (6.08e-3)	unprognostic (1.03e-1)	unprognostic (1.16e-1)	unprognostic (2.17e-2)	unprognostic (2.10e-1)	unprognostic (1.40e-2)	unprognostic (4.13e-2)	unprognostic (1.02e-1)	unprognostic (4.29e-3)	unprognostic (2.12e-2)	unprognostic (5.42e-3)	unprognostic (2.78e-2)	unprognostic (9.97e-3)	unprognostic (1.65e-1)	Oligodendrocytes
TMEM235		ENSG00000204278	Transmembrane protein 235	A6NFC5	17	78231310-78240987	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enriched	Detected in some	6	brain: 107.8	Cell type enriched	Detected in some	23	Oligodendrocytes: 101.7	Cancer enriched	Detected in single	15	glioma: 0.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Not detected	Not detected			HPA053939	Uncertain										Cluster 70: Brain - Nervous system development		Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA053939: AB_2682316					unprognostic (1.47e-1)	unprognostic (6.91e-3)								unprognostic (3.92e-2)	unprognostic (1.71e-1)			Oligodendrocytes
MOG	BTN6, BTNL11	ENSG00000204655	Myelin oligodendrocyte glycoprotein	Q16653	6	29657002-29672372	Disease related genes, Human disease related genes, Predicted membrane proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Receptor	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	brain: 73.8	Cell type enriched	Detected in some	48	Oligodendrocytes: 445.8	Cancer enriched	Detected in single	45	glioma: 15.1	Region enriched	Detected in all	4	cerebral cortex: 73.8	Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes	Region enhanced	Detected in all		white matter: 1396.5	Low region specificity	Detected in all			HPA021873	Enhanced										Cluster 10: Brain - Neuronal signaling	Cluster 33: Skin cancer - Membrane components	Cluster 8: Oligodendrocytes - Myelin sheath organization			HPA021873: AB_1854055	unprognostic (1.33e-1)				unprognostic (1.32e-1)				unprognostic (1.03e-1)	unprognostic (1.05e-2)		unprognostic (7.87e-2)	unprognostic (3.00e-4)	unprognostic (4.89e-2)	unprognostic (4.90e-2)			Oligodendrocytes
TRIM59	Mrf1, RNF104, TRIM57, TSBF1	ENSG00000213186	Tripartite motif containing 59	Q8IWR1	3	160432445-160485773	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 68.4	Cell type enriched	Detected in many	15	Oligodendrocytes: 369.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Skin - Mitotic cells (Skin), Stomach - Mitotic cells (Stomach), Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017750	Uncertain		Approved	Rods & Rings			Yes			Cluster 4: T-regs - Cell cycle regulation	Cluster 76: Brain & Bone marrow - Chromatin organization	Cluster 43: Non-specific - Mitochondria	Cluster 8: Oligodendrocytes - Myelin sheath organization	Rods & Rings		HPA017750: AB_1858312	unprognostic (3.74e-1)	prognostic favorable (4.36e-4)	unprognostic (1.76e-1)	unprognostic (1.03e-1)	unprognostic (1.10e-1)	unprognostic (3.02e-1)	unprognostic (8.00e-4)	unprognostic (1.88e-2)	unprognostic (2.02e-1)	unprognostic (1.72e-1)	prognostic unfavorable (1.15e-5)	unprognostic (1.02e-3)	unprognostic (2.44e-11)	unprognostic (7.92e-2)	unprognostic (2.42e-1)	unprognostic (4.03e-2)	unprognostic (5.91e-3)	Oligodendrocytes
